Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies

J Antimicrob Chemother. 2022 Feb 23;77(3):849-850. doi: 10.1093/jac/dkab438.

Authors

Helen Fifer¹, Ulf Schaefer², Rachel Pitt³, Hester Allen¹, Michaela Day³, Neil Woodford³, Michelle J Cole³

Affiliations

¹ Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London NW9 5HT, UK.
² Bioinformatics Unit - Data, Analytics, and Surveillance, UK Health Security Agency, London NW9 5HT, UK.
³ Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, UK Health Security Agency, London NW9 5HT, UK.

PMID: 34878109
DOI: 10.1093/jac/dkab438

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Infective Agents*
Genomics
Gonorrhea* / diagnosis
Humans
Microbial Sensitivity Tests
Neisseria gonorrhoeae / genetics

Substances

Anti-Infective Agents